Peel Hunt reiterated their hold rating on shares of Assura PLC (LON:AGR) in a report issued on Friday morning. Peel Hunt currently has a GBX 55 ($0.72) target price on the real estate investment trust’s stock.

Separately, Liberum Capital reaffirmed a buy rating and set a GBX 68 ($0.89) price target on shares of Assura PLC in a report on Monday, October 2nd.

Assura PLC (AGR) traded up GBX 0.27 ($0.00) during mid-day trading on Friday, reaching GBX 60.97 ($0.80). The company had a trading volume of 1,520,000 shares, compared to its average volume of 1,860,000. Assura PLC has a 12-month low of GBX 51.35 ($0.68) and a 12-month high of GBX 67.30 ($0.89).

TRADEMARK VIOLATION NOTICE: “Assura PLC’s (AGR) “Hold” Rating Reaffirmed at Peel Hunt” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at

The firm also recently declared a dividend, which was paid on Wednesday, October 18th. Investors of record on Thursday, September 14th were issued a dividend of GBX 0.60 ($0.01) per share. The ex-dividend date was Thursday, September 14th. This represents a yield of 0.91%.

About Assura PLC

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.

Receive News & Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.